輸入代號或公司名稱後按 Enter
4167

松瑞藥

-0.15 (-0.79%)最後更新 2026-09-11
台灣 · 上櫃 · 生技醫療業
18.95474成交張數5.71本益比1.34股價淨值比7.83%殖利率2026-09-11資料日期

每股盈餘

柱為單季 EPS,線為近四季合計;近十年

季度單季 EPS年增近四季 EPS歸屬母公司淨利(億)淨利率ROE(季)ROE(近四季)
2026Q22.333.127.73270.2%19.28%25.76%
2026Q10.27-76.2%0.740.9038.6%2.44%6.43%
2025Q40.27107.1%1.610.8827.6%2.37%14.75%
2025Q30.2485.7%1.470.8028.3%2.19%13.86%
2025Q2-0.05-171.4%1.36-0.17-5.1%-0.45%13.05%
2025Q11.14454.5%1.473.86146.3%10.43%13.59%
2024Q40.137.6%0.530.4716.9%1.34%5.32%
2024Q30.130.520.4312.8%1.24%5.31%
2024Q20.07248.4%0.350.226.3%0.64%3.58%
2024Q10.210.300.7127.4%2.10%3.06%
2023Q40.120.080.4413.9%1.33%0.90%
2023Q3-0.05-111.9%-0.16-0.17-5.7%-0.50%-1.64%
2023Q20.020.280.052.3%0.15%2.87%
2023Q1-0.010.25-0.03-1.2%-0.08%2.66%
2022Q4-0.120.10-0.41-16.0%-1.21%1.09%
2022Q30.390.141.3338.1%3.99%1.42%
2022Q2-0.01-120.9%-0.42-0.02-0.4%-0.05%-4.24%
2022Q1-0.16-166.3%-0.37-0.54-17.6%-1.64%-3.72%
2021Q4-0.08-130.6%0.03-0.29-8.8%-0.88%0.30%
2021Q3-0.17-229.0%0.39-0.57-15.0%-1.68%4.01%
2021Q20.04-37.4%0.690.163.1%0.47%7.22%
2021Q10.24-20.6%0.720.8015.8%2.37%8.35%
2020Q40.2893.8%0.780.9216.1%2.81%9.05%
2020Q30.131398.9%0.650.4510.5%1.45%7.51%
2020Q20.070.520.235.7%0.86%6.43%
2020Q10.300.330.9121.3%4.04%4.81%
2019Q40.14-0.020.4111.0%1.89%-0.24%
2019Q30.01-0.570.020.6%0.10%-7.68%
2019Q2-0.12-0.92-0.35-11.4%-1.86%-13.03%
2019Q1-0.04-0.98-0.14-4.5%-0.73%-14.07%
2018Q4-0.41-1.29-1.12-44.9%-5.88%-17.89%
2018Q3-0.35-657.5%-1.08-0.97-37.1%-4.81%-14.38%
2018Q2-0.19-210.5%-0.67-0.52-16.7%-2.54%-8.80%
2018Q1-0.35-900.7%-0.32-0.98-35.0%-4.64%-4.24%
2017Q4-0.19-320.0%0.08-0.53-16.7%-2.43%1.04%
2017Q30.060.360.174.3%0.76%4.42%
2017Q20.170.070.4610.3%2.11%1.37%
2017Q10.04-0.250.132.8%0.62%-4.27%
2016Q40.09-0.790.204.1%0.93%
2016Q3-0.23-0.49-11.9%-2.31%